• STJ71574 (0. 5µg/ml) staining of Human Adipose lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.

Anti-SERPINA12 antibody (Internal) (STJ71574)

SKU:
STJ71574-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-SERPINA12 (Internal) is suitable for use in ELISA and Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: WB-0.3-1µg/ml
ELISA-antibody detection limit dilution 1:32000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: SERPINA12
Gene ID: 145264
Uniprot ID: SPA12_HUMAN
Immunogen Region: Internal
Accession Number: NP_776249.1
Immunogen Sequence: RARWKHEFDPNVTK
Post Translational Modifications Glycosylation slightly decreases affinity for heparin, but otherwise has no significant effect on KLK7 inhibitory activity or thermal stability of the protein.
Function Adipokine that modulates insulin action by specifically inhibiting its target protease KLK7 in white adipose tissues.
Protein Name Serpin A12
Ol-64
Visceral Adipose Tissue-Derived Serine Protease Inhibitor
Vaspin
Visceral Adipose-Specific Serpin
Cellular Localisation Secreted
Alternative Antibody Names Anti-Serpin A12 antibody
Anti-Ol-64 antibody
Anti-Visceral Adipose Tissue-Derived Serine Protease Inhibitor antibody
Anti-Vaspin antibody
Anti-Visceral Adipose-Specific Serpin antibody
Anti-SERPINA12 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance